Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections
- 1 February 2017
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 17 (2) , e30-e41
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Pharmaceutically active secondary metabolites of marine actinobacteriaMicrobiological Research, 2014
- The Bis(Indolyl)Imidazole Alkaloid Nortopsentin A Exhibits Antiplasmodial ActivityAntimicrobial Agents and Chemotherapy, 2013
- Systematic identification of synergistic drug pairs targeting HIVNature Biotechnology, 2012
- Lessons from the Past and Charting the Future of Marine Natural Products Drug Discovery and Chemical BiologyChemistry & Biology, 2012
- Accessing the Hidden Majority of Marine Natural Products through MetagenomicsChemBioChem, 2011
- Artemisinin-based combination therapies: a vital tool in efforts to eliminate malariaNature Reviews Microbiology, 2009
- Metagenomic approaches to natural products from free-living and symbiotic organismsNatural Product Reports, 2009
- A new antimalarial polyether from a marine Streptomyces sp. H668Tetrahedron Letters, 2008
- Benefits of using multiple first-line therapies against malariaProceedings of the National Academy of Sciences, 2008
- Capisterones A and B, which Enhance Fluconazole Activity in Saccharomyces cerevisiae, from the Marine Green Alga Penicillus capitatusJournal of Natural Products, 2006